A small molecular weight catalytic metalloporphyrin antioxidant with superoxide dismutase (SOD) mimetic properties protects lungs from radiation-induced injury

Free Radical Biology and Medicine

Volumn 33, Issue 6, 2002, Pages 857-863

  Vujaskovic, Zeljko ^a   Batinic Haberle, Ines ^a   Rabbani, Zahid N ^a   Feng, Qin fu ^b   Kang, Song K ^a   Spasojevic, Ivan ^a   Samulski, Thaddeus V ^a   Fridovich, Irwin ^a   Dewhirst, Mark W ^a   Anscher, Mitchell S ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b CANCER HOSPITAL   (China)

Author keywords

Free radicals; Pulmonary toxicity; Radiation; Rat; Superoxide dismutase mimetics; Transforming growth factor

Indexed keywords

AEOL 10113; COLLAGEN; HYDROXYPROLINE; METALLOPORPHYRIN; SUPEROXIDE DISMUTASE; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATALYST; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; FEMALE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IONIZING RADIATION; LUNG INJURY; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIATION DOSE; RADIATION INJURY; RADIATION PROTECTION; RAT;

ANIMALS; ANTIOXIDANTS; COLLAGEN; FEMALE; FIBROSIS; FREE RADICALS; HYDROXYPROLINE; IMMUNOHISTOCHEMISTRY; LUNG; METALLOPORPHYRINS; RADIATION INJURIES; RATS; RATS, INBRED F344; RESPIRATION; SUPEROXIDE DISMUTASE; THORACIC NEOPLASMS; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 2942713709     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(02)00980-2     Document Type: Article

References (39)

1. Martel M.K., Ten Haken R.K., Hazuka M.B. Dose-volume histogram and 3-D treatment planning evaluation of patients with pneumonitis. Int. J. Radiat. Oncol. Biol. Phys. 28:1994;575-581.
2. Roach M., Gandara D.R., You H.S. Radiation pneumonitis following combined modality therapy for lung cancer analysis of prognostic factors . J. Clin. Oncol. 13:1995;2606-2612.
3. Lingos T.I., Recht A., Vicini F. Radiation pneumonitis in breast cancer patients treated with conservative surgery and radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 21:1991;355-360.
4. Rothwell R.I., Kelly S.A., Joslin C.A. Radiation pneumonitis in patients treated for breast cancer. Radiother. Oncol. 4:1985;9-14.
5. Vujaskovic Z., Marks L.B., Anscher M.S. The physical parameters and molecular events associated with radiation-induced lung toxicity. Semin. Radiat. Oncol. 10:2000;296-307.
6. Rubin P., Johnston C.J., Williams J.P. A perpetual cascade of cytokines postirradiation leads to pulmonary fibrosis. Int. J. Radiat. Oncol. Biol. Phys. 33:1995;99-109.
7. Riley P.A. Free radicals in biology oxidative stress and the effects of ionizing radiation . Int. J. Radiat. Biol. 65:1994;27-33.
8. Vujaskovic Z., Anscher M.S., Feng Q.F. Radiation-induced hypoxia may perpetuate late normal tissue injury. Int. J. Radiat. Oncol. Biol. Phys. 50:2001;851-855.
9. Haroon Z.A., Raleigh J.A., Greenberg C.S. Early wound healing exhibits cytokine surge without evidence of hypoxia. Ann. Surg. 231:2000;137-147.
10. McCord J.M., Fridovich I. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J. Biol. Chem. 244:1969;6049-6055.
11. McCord J.M., Fridovich I. The utility of superoxide dismutase in studying free radical reactions. I. Radicals generated by the interaction of sulfite; dimethyl sulfoxide; and oxygen. J. Biol. Chem. 244:1969;6056-6063.
12. Quinlan T., Spivack S., Mossman B.T. Regulation of antioxidant enzymes in lung after oxidant injury. Environ. Health Perspect. 102:(Suppl. 2):1994;79-87.
13. Tsan M.F. Superoxide dismutase and pulmonary oxygen toxicity. Proc. Soc. Exp. Biol. Med. 214:1997;107-113.
14. Somack R., Saifer M.G., Williams L.D. Preparation of long-acting superoxide dismutase using high molecular weight polyethylene glycol (41,000-72,000 daltons). Free Radic. Res. Commun. 12-13:(Pt. 2):1991;553-562.
15. DiGregorio K.A., Cilento E.V., Lantz R.C. A kinetic model of superoxide production from single pulmonary alveolar macrophages. Am. J. Physiol. 256:1989;C405-C412.
16. Riley D.P. Manganese macrocyclic ligand complexes as mimics of superoxide dismutase. J. Am. Chem. Soc. 116:1994;387.
17. Salvemini D., Wang Z.Q., Zweier J.L. A nonpeptidyl mimic of superoxide dismutase with therapeutic activity in rats. Science. 286:1999;304-306.
18. Baker K., Marcus C.B., Huffman K. Synthetic combined superoxide dismutase/catalase mimetics are protective as a delayed treatment in a rat stroke model a key role for reactive oxygen species in ischemic brain injury . J. Pharmacol. Exp. Ther. 284:1998;215-221.
19. Melov S., Ravenscroft J., Malik S. Extension of life span with superoxide dismutase/catalase mimetics. Science. 289:2000;1567-1569.
20. Batinic-Haberle I., Benov L., Spasojevic I. The ortho effect makes manganese(III) meso-tetrakis(N-methylpyridinium-2-yl)porphyrin a powerful and potentially useful superoxide dismutase mimic. J. Biol. Chem. 273:1998;24521-24528.
21. Spasojevic I., Batinic-Haberle I. Manganese (III) complexes with porphyrin and related compound as catalytic scavenger of superoxide. Inorg. Chem. Acta. 317:2001;230-243.
22. Batinic-Haberle I. Manganese porphyrin and related compound as mimics of superoxide dismutase. Methods Enzymol. 349:2002;223-233.
23. Lefaix J.L., Delanian S., Leplat J.J. Successful treatment of radiation-induced fibrosis using Cu/Zn-SOD and Mn-SOD an experimental study . Int. J. Radiat. Oncol. Biol. Phys. 35:1996;305-312.
24. Delanian S., Baillet F., Huart J. Successful treatment of radiation-induced fibrosis using liposomal Cu/Zn superoxide dismutase clinical trial . Radiother. Oncol. 32:1994;12-20.
25. Epperly M., Bray J., Kraeger S. Prevention of late effects of irradiation lung damage by manganese superoxide dismutase gene therapy. Gene Ther. 5:1998;196-208.
26. Epperly M.W., Defilippi S., Sikora C. Intratracheal injection of manganese superoxide dismutase (MnSOD) plasmid/liposomes protects normal lung but not orthotopic tumors from irradiation. Gene Ther. 7:2000;1011-1018.
27. Epperly M.W., Kagan V.E., Sikora C.A. Manganese superoxide dismutase-plasmid/liposome (MnSOD-PL) administration protects mice from esophagitis associated with fractionated radiation. Int. J. Cancer. 96:2001;221-231.
28. Law M.P. Vascular permeability and late radiation fibrosis in mouse lung. Radiat. Res. 103:1985;60-76.
29. Ashcroft T., Simpson J.M., Timbrell V. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J. Clin. Pathol. 41:1988;467-470.
30. Hsu S.M., Raine L., Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques a comparison between ABC and unlabeled antibody (PAP) procedures . J. Histochem. Cytochem. 29:1981;577-580.
31. Poli G., Parola M. Oxidative damage and fibrogenesis. Free Radic. Biol. Med. 22:1997;287-305.
32. Martin M., Lefaix J., Delanian S. TGF-β1 and radiation fibrosis a master switch and a specific therapeutic target? Int. J. Radiat. Oncol. Biol. Phys. 47:2000;277-290.
33. Petkau A., Chelack W.S. Radioprotection by superoxide dismutase of macrophage progenitor cells from mouse bone marrow. Biochem. Biophys. Res. Commun. 119:1984;1089-1095.
34. Petkau A. Radiation protection by superoxide dismutase. Photochem. Photobiol. 28:1978;765-774.
35. Petkau A., Chelack W.S., Pleskach S.D. Protection by superoxide dismutase of white blood cells in X-irradiated mice. Life Sci. 22:1978;867-882.
36. Schieffer B., Luchtefeld M., Braun S. Role of NAD(P)H oxidase in angiotensin II-induced JAK/STAT signaling and cytokine induction. Circ. Res. 87:2000;1195-1201.
37. Griendling K.K., Ushio-Fukai M. Reactive oxygen species as mediators of angiotensin II signaling. Regul. Pept. 91:2000;21-27.
38. Schmidt-Ullrich R.K., Dent P., Grant S. Signal transduction and cellular radiation responses. Radiat. Res. 153:2000;245-257.
39. Zhong Z., Arteel G.E., Connor H.D. Cyclosporin A increases hypoxia and free radical production in rat kidneys prevention by dietary glycine . Am. J. Physiol. 275:1998;F595-F604.